Vimarsana
Biggest News Aggregation in the World

Edwards Evoque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edwards Evoque. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edwards Evoque Today - Breaking & Trending Today

FDA approves Abbott TriClip TEER system - Vimarsana News

FDA approves Abbott TriClip TEER system

Abbott (NYSE: ABT) announced that the FDA granted approval for its first-of-ts-kind TriClip transcatheter edge-to-edge repair (TEER) system.

FDA advisory committee votes in favor of Abbott TriClip - Vimarsana News

FDA advisory committee votes in favor of Abbott TriClip

Abbott (NYSE: ABT) announced today that an FDA advisory committee ruled that the benefits of its TriClip outweigh the risks.

Edwards wins FDA approval for Evoque replacement tricuspid valve - Vimarsana News

Edwards wins FDA approval for Evoque replacement tricuspid valve

Edwards Lifesciences (NYSE:EW) announced today that the FDA granted approval for its Evoque tricuspid valve replacement system.

Edwards announces positive results for Evoque valve replacement - Vimarsana News

Edwards announces positive results for Evoque valve replacement

Edwards Lifesciences (NYSE:EW) announced that one-year results from the TRISCEND study demonstrated favorable outcomes.

Pascal Tricuspid Repair Outcomes Durable at 1 Year: CLASP-TR - Vimarsana News

Pascal Tricuspid Repair Outcomes Durable at 1 Year: CLASP-TR

Three-fourths of patients had at least a two-grade reduction in tricuspid regurgitation, and 88% were alive 1 year after treatment with the experimental device.